Suppr超能文献

新型蒽环类药物ME2303(FAD - 104)的生物学特性

Biological properties of ME2303 (FAD-104), a new anthracycline.

作者信息

Omoto S, Kondo S, Fukatsu S, Takeuchi T, Umezawa K, Tsuchiya T, Umezawa S

机构信息

Meiji Seika Kaisha, Ltd., Tokyo, Japan.

出版信息

Drugs Exp Clin Res. 1988;14(7):435-9.

PMID:3240704
Abstract

ME2303 (FAD-104) is a new anthracycline antibiotic whose structure is characterized by the presence of a 2'-fluoro atom and the lack of a 3'-amino group in the sugar moiety. Its cytocidal activity is superior to or equal to that of adriamycin (ADM). The LD50 value of ME2303 was about 140 mg/kg i.v. in mice and this value was about 7-fold higher than that of ADM. ME2303 was administered intravenously to Golden strain hamsters at doses of 25, 50, 75 and 150 mg/kg and the ECG was examined. From ECG changes, it seems that ME2303 did not show any effect on the heart in acute toxicity. Mutagenicity was recognized as with ADM in the back-mutation test.

摘要

ME2303(FAD - 104)是一种新型蒽环类抗生素,其结构特点是在糖部分存在2'-氟原子且缺少3'-氨基。其杀细胞活性优于或等同于阿霉素(ADM)。ME2303在小鼠体内静脉注射的半数致死量(LD50)约为140mg/kg,该值比阿霉素高约7倍。以25、50、75和150mg/kg的剂量给金黄仓鼠静脉注射ME2303,并检查心电图。从心电图变化来看,ME2303在急性毒性中似乎对心脏没有任何影响。在回复突变试验中,ME2303与阿霉素一样具有致突变性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验